aHUS Registry
Research type
Research Database
IRAS ID
259317
Contact name
Benjamin Miller
Contact email
Research summary
An Observational, Non-Interventional, Multi-center, Multi-national, Study of Patients with Atypical Hemolytic-Uremic Syndrome (aHUS Regsitry)
REC name
North East - Newcastle & North Tyneside 2 Research Ethics Committee
REC reference
19/NE/0033
Date of REC Opinion
21 Mar 2019
REC opinion
Further Information Favourable Opinion
Data collection arrangements
The following data is collected via eCRF at each participating site:
demographics, clinical characteristics, signs and symptoms of TMA complications/manifestations, laboratory data, vital signs, special events of interest, adverse events, concomitant medications and procedures, disposition.Research programme
Patients with aHUS
Research database title
An Observational, Non-Interventional, Multi-center, Multi-national, Study of Patients with Atypical Hemolytic-Uremic Syndrome (aHUS Regsitry)
Establishment organisation
Alexion Pharmaceuticals Inc.
Establishment organisation address
100 College Street
New Haven, CT
United States of America
06510